{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T19:21:46Z","timestamp":1785871306569,"version":"3.56.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ijgc.2026.104565","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T16:46:46Z","timestamp":1770914806000},"page":"104565","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Fertility and obstetric outcomes after fertility-sparing treatment for early-stage endometrial cancer and atypical hyperplasia: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"36","author":[{"given":"Rong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchun","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ijgc.2026.104565_bib1","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1021\/acs.jcim.1c00754","article-title":"SynthI: a new open-source tool for Synthon-based library design","volume":"62","author":"Zabolotna","year":"2021","journal-title":"J Chem Inf Model"},{"issue":"6","key":"10.1016\/j.ijgc.2026.104565_bib21","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/IGC.0b013e3181aae1fb","article-title":"Conservative treatment with progestin and pregnancy outcomes in endometrial cancer","volume":"19","author":"Hahn","year":"2009","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104565_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2013.11.001","article-title":"Reproductive and oncologic outcomes after progestin therapy for endometrial complex atypical hyperplasia or carcinoma","volume":"210","author":"Kudesia","year":"2014","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104565_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/ijgc-2018-000036","article-title":"Pregnancy and oncologic outcomes after fertility-sparing management for early stage endometrioid endometrial cancer","volume":"29","author":"Chae","year":"2019","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104565_bib24","first-page":"291","article-title":"Clinical outcomes analysis of fertility-preserving therapy for atypical endometrial hyperplasia and early endometrial carcinoma","volume":"44","author":"He","year":"2022","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"issue":"4","key":"10.1016\/j.ijgc.2026.104565_bib25","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/jog.15872","article-title":"Oncologic, fertility, and obstetric outcomes with MPA therapy in women with endometrial cancer and atypical endometrial hyperplasia","volume":"50","author":"Takeda","year":"2024","journal-title":"J Obstet Gynaecol Res"},{"issue":"9","key":"10.1016\/j.ijgc.2026.104565_bib26","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1111\/jog.16038","article-title":"Update on the oncologic and obstetric outcomes of medroxyprogesterone acetate treatment for atypical endometrial hyperplasia and endometrial cancer","volume":"50","author":"Tamauchi","year":"2024","journal-title":"J Obstet Gynaecol Res"},{"issue":"1","key":"10.1016\/j.ijgc.2026.104565_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/03630242.2020.1824956","article-title":"Micronized progesterone, progestins, and menopause hormone therapy","volume":"61","author":"Hipolito Rodrigues","year":"2020","journal-title":"Women Health"},{"key":"10.1016\/j.ijgc.2026.104565_bib3","article-title":"Chemokine ligand 14 correlates with immune cell infiltration in the gastric cancer microenvironment in predicting unfavorable prognosis","volume":"15","author":"Lu","year":"2024","journal-title":"Front Pharmacol"},{"issue":"6","key":"10.1016\/j.ijgc.2026.104565_bib4","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1556\/650.2022.32375","article-title":"A term\u00e9kenys\u00e9g megorz\u00e9se daganatos betegs\u00e9gekben. Egy hazai felm\u00e9r\u00e9s tapasztalatai [Fertility preservation in cancer patients]","volume":"163","author":"Vesztergom","year":"2022","journal-title":"Orv Hetil"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104565_bib5","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.nurt.2009.01.009","article-title":"Hormonal therapies: progesterone","volume":"6","author":"Herzog","year":"2009","journal-title":"Neurotherapeutics"},{"issue":"5","key":"10.1016\/j.ijgc.2026.104565_bib6","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.fertnstert.2016.06.040","article-title":"Polycystic ovary syndrome in type 2 diabetes: does it predict a more severe phenotype?","volume":"106","author":"Sim","year":"2016","journal-title":"Fertil Steril"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104565_bib7","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00404-025-08049-9","article-title":"Sleep disorders and psychological comorbidities in women with polycystic ovary syndrome - a cross-sectional study","volume":"312","author":"Decrinis","year":"2025","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ijgc.2026.104565_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107575","article-title":"The AMPK modulator metformin as adjunct to methotrexate in patients with rheumatoid arthritis: a proof-of-concept, randomized, double-blind, placebo-controlled trial","volume":"95","author":"Abdallah","year":"2021","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"10.1016\/j.ijgc.2026.104565_bib9","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1080\/14740338.2024.2348561","article-title":"A review on side effect management of second-generation antipsychotics to treat schizophrenia: a drug safety perspective","volume":"23","author":"Strube","year":"2024","journal-title":"Expert Opin Drug Saf"},{"issue":"4","key":"10.1016\/j.ijgc.2026.104565_bib10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/cmt.6.4.273.277","article-title":"Hormone therapy and endometrial angiogenesis","volume":"6","author":"Mirkin","year":"2003","journal-title":"Climacteric"},{"issue":"5","key":"10.1016\/j.ijgc.2026.104565_bib11","doi-asserted-by":"crossref","first-page":"356","DOI":"10.48095\/cccg2022356","article-title":"Female fertility preservation in cancer patients [Zachov\u00e1n\u00ed fertility u onkologick\u00fdch pacientek]","volume":"87","author":"Tomilov\u00e1","year":"2022","journal-title":"Cesk Gynekol"},{"issue":"2","key":"10.1016\/j.ijgc.2026.104565_bib12","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/13625180902747425","article-title":"Parenteral administration of progestins for hormonal replacement therapy","volume":"14","author":"Nath","year":"2009","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"6","key":"10.1016\/j.ijgc.2026.104565_bib13","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/risa.12933","article-title":"Characterizing risk for cumulative risk assessments","volume":"38","author":"MacDonell","year":"2017","journal-title":"Risk Anal"},{"issue":"11","key":"10.1016\/j.ijgc.2026.104565_bib14","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/journalofethics.2016.18.11.pfor2-1611","article-title":"Transgender reproductive choice and fertility preservation","volume":"18","author":"Mitu","year":"2016","journal-title":"AMA J Ethics"},{"key":"10.1016\/j.ijgc.2026.104565_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1199582","article-title":"Editorial: fertility-preserving and fertility-sparing treatment approaches in gynecologic malignancies","volume":"13","author":"Raimondo","year":"2023","journal-title":"Front Oncol"},{"issue":"4","key":"10.1016\/j.ijgc.2026.104565_bib16","doi-asserted-by":"crossref","first-page":"e294","DOI":"10.3747\/co.22.2334","article-title":"Fertility preservation in reproductive-age women facing gonadotoxic treatments","volume":"22","author":"Roberts","year":"2015","journal-title":"Curr Oncol"},{"issue":"3","key":"10.1016\/j.ijgc.2026.104565_bib17","first-page":"223","article-title":"Options for fertility preservation in children","volume":"15","author":"Javed","year":"2018","journal-title":"Pediatr Endocrinol Rev"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X26000976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X26000976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T13:28:28Z","timestamp":1776346108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X26000976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1048891X26000976"],"URL":"https:\/\/doi.org\/10.1016\/j.ijgc.2026.104565","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fertility and obstetric outcomes after fertility-sparing treatment for early-stage endometrial cancer and atypical hyperplasia: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijgc.2026.104565","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Society of Gynaecological Oncology and the International Gynecologic Cancer Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104565"}}